Ethyl 3-(4-Chlorophenyl)-1H-pyrazole-5-carboxylate, 95.0%, 250mg

3-Oxo-4-o-tolyl-butyric acid ethyl ester, 1g

(5S,8S,10aR)-3-((Benzyloxy)carbonyl)-5-((tert-butoxycarbonyl)amino)-6-oxodecahydropyrrolo[1,2-a][1,5]diazocine-8-carboxylic acid, 97%, 100mg

(R)-1-N-Boc-Pipecolinic acid, 95.0%, 25g

Tert-butyl 1-(hydroxymethyl)hexahydropyrrolo[3,4-c]pyrrole-2(1H)-carboxylate hydrochloride, 95%, 1g

(S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-5-methylhex-4-enoic acid, 98+%, 100mg

2-(Piperidin-4-ylmethyl)pyrimidine, 98%, 250mg

Solution étalon d'hafnium ICP, ROTI®Star, 10000 mg/l Hf, densité (D) ~1 g/cm³

3-[4-(propan-2-yl)phenyl]butanoic acid, 95+%, 250mg

2-Phenyl-4-(trifluoromethyl)-1H-imidazole, 95.0%, 1g

1-(5-Bromo-2-iodophenyl)ethanone, 95+%, 25g

3-Bromo-N,N-di-p-tolylaniline, 95.0%, 1g

6-Chloropyridine-2-boronic acid, 95.0%, 100mg